Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-18

Clinical Trial Update: BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis [NA]

View source ↗

Summary

Registration update for the BRAVE program aiming to improve safety and reduce violence risk in individuals with early psychosis; the study is not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Howard University | Conditions: Violence Risk, Early Psychosis | NA | Status: NOT_YET_RECRUITING